Cellebrite (NASDAQ: CLBT) closed its acquisition of Corellium on December 2, 2025, paying an enterprise value of $170 million. The deal consists of $150 million in cash at closing, $20 million in equity, and a potential $30 million earn‑out tied to performance milestones over the next two years.
Corellium’s ARM‑based virtualization platform, which has been used by Cellebrite’s mobile research teams for roughly five years, now becomes a core component of Cellebrite’s digital investigation suite. The technology enables researchers to create virtual device environments, allowing live simulation and vulnerability discovery without physical hardware. This capability is expected to accelerate the development of mobile and IoT security tools and broaden Cellebrite’s addressable market in both public‑sector law‑enforcement agencies and private‑sector enterprises.
The transaction was approved by the Committee on Foreign Investment in the United States (CFIUS) under a national‑security agreement with U.S. government agencies. The approval confirms that the technology does not pose a national‑security risk and allows the deal to close without further regulatory delay. Corellium’s chief technology officer, Chris Wade, has joined Cellebrite as CTO, bringing deep expertise in virtualization and a track record of scaling security platforms.
Financially, Cellebrite said the acquisition will not materially affect its Q4 or full‑year 2025 results, representing only one month of Corellium’s revenue and costs in the current fiscal period. The company’s Q3 2025 earnings showed revenue of $126 million, up 18% year‑over‑year, driven by strong subscription growth and operational efficiency. The earnings beat analysts’ consensus by $0.05 per share, a 55% beat, largely due to disciplined cost control and a favorable mix of high‑margin subscription contracts.
Strategically, the acquisition positions Cellebrite to compete more aggressively in the growing mobile and IoT security market. Corellium’s virtualization technology complements Cellebrite’s existing forensic tools, creating a unified platform that can extract data, simulate device behavior, and identify vulnerabilities. This integration is expected to open new revenue streams in defense, intelligence, and enterprise security sectors, where demand for secure mobile development is accelerating.
Management highlighted the strategic fit in a statement: “We are thrilled to welcome the Corellium team to the Cellebrite family. Their technology expands our capabilities in mobile and IoT vulnerability testing and strengthens our AI‑driven product roadmap.” CEO Thomas E. Hogan emphasized that the acquisition “goes beyond technology, adding talent and accelerating innovation across our platform.”
The deal also signals Cellebrite’s continued focus on expanding its global footprint. The company serves over 7,000 law‑enforcement agencies, defense and intelligence organizations, and enterprises in more than 100 countries. By adding Corellium’s expertise, Cellebrite can deepen its penetration in these markets and accelerate the adoption of its digital investigation solutions.
Overall, the acquisition is a material event that enhances Cellebrite’s competitive position, expands its product portfolio, and provides a foundation for future growth in mobile and IoT security. The transaction aligns with industry trends toward virtualization, DevSecOps, and software security verification, positioning Cellebrite to capture a larger share of the rapidly expanding digital forensics market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.